NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Prepaid Assets of $6.7 million for Q4 2025, up 102.67% year-on-year from $3.3 million in Q4 2024, and up 48.37% on a QoQ basis from $4.5 million in Q3 2025.
NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Prepaid Assets for 8 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.
- Quarterly Prepaid Assets rose 102.67% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 102.67% YoY) and the FY2025 annual result came in at $6.7 million, up 102.67% from the prior year.
- Prepaid Assets climbed to $6.7 million in Q4 2025 per NBP's latest filing, from $4.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for NBP reached as high as $29.8 billion in Q4 2021 and fell as low as $2.0 million in Q2 2025.
- A 5-year average of $2.3 billion and a median of $7.2 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 101093.59% — and 2022, when it plunged 99.96%.
- Year by year, Prepaid Assets stood at $29.8 billion in 2021, then tumbled by 99.96% to $11.3 million in 2022, then tumbled by 36.01% to $7.2 million in 2023, then plunged by 54.38% to $3.3 million in 2024, then soared by 102.67% to $6.7 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.7 million, $4.5 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.68 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 22.99 Mn |
| Dec 31, 2023 | 7.22 Mn |
| Jun 30, 2023 | 14.11 Mn |
| Dec 31, 2022 | 11.29 Mn |
| Jun 30, 2022 | 15.08 Mn |
| Dec 31, 2021 | 29.85 Bn |
| Jun 30, 2021 | 31.04 Mn |
| Dec 31, 2020 | 29.49 Mn |
| Sep 30, 2020 | 32.38 Mn |
| Jun 30, 2020 | 18.56 Mn |
| Dec 31, 2019 | 19.30 Mn |
| Dec 31, 2018 | 12.87 Mn |